Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.
Unlearn, founded in 2017, uses machine learning to create digital twins of clinical trial participants before being randomized in a controlled trial.
The...
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company's FDA-cleared SimpleSense wearable reads patient vitals, such...
A team of engineers at The Chinese University of Hong Kong has developed an AI-based blood pressure management system featuring a large language model from DeepSeek.
HOW IT WORKS
The system called Dr PAI (personalised AI doctor) integrates wearable technology with DeepSeek to enable 24/7 monitoring and tracking of dynamic blood pressure changes and heart rate variability. It also collects...
Vuno invests $2M, sells lung AI in Japan to rival
Vuno has invested in and sold its lung disease diagnosis AI technology in Japan to its rival Korean company Coreline Soft.
The two companies recently entered into a strategic partnership to jointly raise their competitiveness in the growing global medical imaging AI segment.
Vuno invested 3.4 billion won ($2.3 million) in Coreline Soft, to which...
EpiWatch, the Apple Watch-based epilepsy management company spun out from Johns Hopkins, announced it received FDA 510(k) clearance for its continuous seizure monitor platform that utilizes the popular wearable to detect and alert for tonic-clonic seizures.
Tonic-clonic seizures, or grand mal seizures, are a type of seizure that affects the whole brain and can cause violent muscle contractions...
Neuromod, a medical device company out of Dublin focused on treating tinnitus, secured €10 million ($10.9 million) in equity financing, expanding its Series B raise.
The raise builds on the company's €10.5 million ( $11.43 million) oversubscribed Series B financing in 2020.
Existing investors Fountain Healthcare Partners and Panakès Partners led the round.
WHAT IT DOES
Neuromod is a global...
Hinge Health, a digital musculoskeletal care platform, filed for an IPO on Monday with the U.S. Securities and Exchange Commission to go public under the symbol HNGE, despite recent stock market volatility due to uncertainty around U.S. trade policies.
The San Francisco-based company, founded in 2015, provides individuals with musculoskeletal conditions access to health coaches, orthopedic...
Hybrid musculoskeletal care provider Vori Health announced it has raised an oversubscribed $53 million in a Series B funding round.
NEA led the round with participation from Echo Health Ventures, Max Ventures, AlleyCorp and Intermountain Health's Intermountain Ventures.
WHAT IT DOES
Vori Health offers virtual and in-person musculoskeletal care. The company connects patients with specialty medical...
Digital chronic disease management platform Health2Sync has recently raised $20 million in a Series C funding round led by Taiwania Capital. Wistron, Pegatron, BE Health Ventures, ABIES Capital, and Cathay Venture also joined the round.
This latest investment brings its total capital raised since its founding in 2013 to over $30 million.
WHAT IT'S FOR
In a media release, the company said it...
Digital chronic condition management company DarioHealth reported full-year 2024 revenue of $27 million, a 32.9% increase from $20.4 million in 2023, attributed to a consolidation of Twill's revenue and increased revenue from its commercial channels.
The New York-based company acquired Twill in early 2024.
The company's full-year B2B2C, employers and health plans recurring revenues increased 300...
